Immix Biopharma | Investor Presentation Deck

Slide schematic 5/5

chart 3/3 disclaimer 1/1 title 1/1

Components 5

bar-vertical line line disclaimer headline

Tools 1

chart/line: Non-Sarcoma Cancers | iMX-110 Monotherapy longitudinal response, chart/line: Soft Tissue Sarcoma | iMX-110 Monotherapy longitudinal response, chart/bar-vertical: Best % Change from Baseline in Size of Target Lesions

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

Includes waterfall charts and longitudinal patient response plots. Source note provided at bottom.